Follow us...


Search News Archives





View Channel

Laboratory Products



View Channel

Special Offers and Promotions


Microscopy | Image Analysis



View Channel

Separation Science



View Channel

Coronavirus (COVID-19)



View Channel

Research & Case Studies



View Channel

Conferences | Events

National Institute for Public Health and the Environment selected iVention to deliver iLES LIMS for the Neonatal Bloodspot Prick Screening (NHS).

publication date: Aug 16, 2018
author/source: iVention B.V.

CEO iVention Oscar Kox, MBA (in the middle) signs NHS LIMS Agreement in presence of R.M. (Rob) Riesmeijer, MSc MScPH Head of the Department of Vaccine Supply and Prevention Programmes (left) and Drs. Jaap van Delden, MBA, Head of the Centre for Population Screening at the RIVM.

iVention is proud to announce that RIVM via a European Tender has chosen iLES as their new LIMS for NHS to replace the current LIMS system.

“The assignment is an essential milestone in our ambition to increase our presence in the Healthcare industry. The winning bid proves that our innovative approach provides great benefits to organizations like RIVM in their search for a more flexible, configurable and future-proof NHS LIMS. As our system is based on the latest technologies it offers unrestricted scalability and brings down the total cost of ownership”, says Oscar Kox, CEO of iVention.

The Neonatal heel prick screening is a nationwide screening program for babies in the first week after birth. Annually approximately 170.000 newborns in the Netherlands receive the heel prick. The heel prick screening is the longest running nationwide screening program in public healthcare in the Netherlands.
The analysis of the heel prick blood provides important information about currently 19 rare, often hereditary, serious diseases. Early detection of these diseases is crucial to limit or prevent serious damage to health by timely treatment of babies that are born mostly symptomless. The blood tests are performed by five screening laboratories, of which the laboratory of the RIVM acts as a reference laboratory. The screening laboratories are responsible for the analysis of the heel prick blood and adequate reporting of the results. High demands are placed on the reliability and quality of the blood tests. The analyses must be carried out in a timely manner and with great care.

In July 2015, the Minister of VWS took up the recommendation of the Health Council to add 14 disorders to the screening program. With the expansion plans of the heel prick program to 31 diseases the number of functionalities and complexity will increase significantly. As the current LIMS system is not sufficiently equipped for these changes replacement is necessary. Therefore RIVM published a European Public tender for the delivery, implementation and maintenance of a LIMS for neonatal heel prick screening.

The European tender for this NHS project started early 2017 and finally 4 vendors were selected for a final proposal and a dedicated demonstration to show their fit to the RIVM requirements. Critical elements in the delivery of the new NHS-LIMS include integration with lab equipment, interpretation functionality (decision rules), and the administrative process support system. The full digitalization of the information on the heel prick card with a mobile App has been determined as a potential added value for the near future. Finally iVention was selected as the best qualified partner for the assignment. The agreement was signed on July 5th at RIVM in Bilthoven.

“Great teamwork, passion, talent and challenging work in iVention formed the basis for this new success” according to Oscar Kox, the CEO of iVention.

About RIVM
How can we keep ourselves and our environment healthy? That is the challenge facing government authorities at all levels, from the local to the international. The Dutch National Institute for Public Health and the Environment (RIVM) conducts research and provides advice to assist them in this task.
RIVM works to prevent and control outbreaks of infectious diseases. We promote public health and consumer safety, and we help to protect the quality of the environment. RIVM collects and collates knowledge and information from various sources, both national and international. We apply this knowledge ourselves, and we place it at the disposal of policy-makers, researchers, regulatory authorities and the general public. Each year, RIVM produces numerous reports on all aspects of public health, nutrition and diet, health care, disaster management, nature and the environment. RIVM has a total of approximately 1,500 staff and their headquarters is in Bilthoven (NL).

About iVention
iVention provides laboratories in a wide range of industries with a modern Lab Execution System that combines LIMS, ELN and SDMS features in a single Informatics Platform. The powerful iLES Platform is fully web based, highly flexible and scalable and can be easily deployed from the Cloud and used on any mobile device. iVention is ISO 27001 certified and all our applications are compliant with Good Laboratory Practice (GLP) as well as 21 CFR part 11 guidelines.

more news from iVention

If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month


Today's Picks




Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners